| Multiplexed immunohistochemistry for molecular and immune profiling in lung cancer—just about ready for prime-time? P Hofman, C Badoual, F Henderson, L Berland, M Hamila, E Long-Mira, ... Cancers 11 (3), 283, 2019 | 127 | 2019 |
| Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors L Berland, S Heeke, O Humbert, A Macocco, E Long-Mira, S Lassalle, ... Journal of thoracic disease 11 (Suppl 1), S71, 2019 | 87 | 2019 |
| FuncPEP: a database of functional peptides encoded by non-coding RNAs MP Dragomir, GC Manyam, LF Ott, L Berland, E Knutsen, C Ivan, ... Non-coding RNA 6 (4), 41, 2020 | 66 | 2020 |
| A new world of biomarkers and therapeutics for female reproductive system and breast cancers: circular RNAs AM Tran, GM Chalbatani, L Berland, M Cruz De los Santos, P Raj, ... Frontiers in cell and developmental biology 8, 50, 2020 | 57 | 2020 |
| Nanobodies for medical imaging: about ready for prime time? L Berland, L Kim, O Abousaway, A Mines, S Mishra, L Clark, P Hofman, ... Biomolecules 11 (5), 637, 2021 | 35 | 2021 |
| 17β-estradiol promotes extracellular vesicle release and selective miRNA loading in ERα-positive breast cancer R Drula, B Pardini, X Fu, MC De los Santos, A Jurj, L Pang, SM El-Daly, ... Proceedings of the National Academy of Sciences 120 (23), e2122053120, 2023 | 16 | 2023 |
| Direct N-or C-Terminal Protein Labeling Via a Sortase-Mediated Swapping Approach M Cong, S Tavakolpour, L Berland, H Glockner, B Andreiuk, ... Bioconjugate chemistry 32 (11), 2397-2406, 2021 | 7 | 2021 |
| A CAR enhancer increases the activity and persistence of CAR T cells T Rakhshandehroo, SR Mantri, H Moravej, BBV Louis, A Salehi Farid, ... Nature Biotechnology, 1-12, 2024 | 5 | 2024 |
| Further knowledge and developments in resistance mechanisms to immune checkpoint inhibitors L Berland, Z Gabr, M Chang, M Ilié, V Hofman, G Rignol, F Ghiringhelli, ... Frontiers in Immunology 15, 1384121, 2024 | 5 | 2024 |
| Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer W Khatir, O Humbert, J Benzaquen, C Bontoux, J Neels, L Berland, ... Clinical and Translational Medicine 12 (8), e1018, 2022 | 5 | 2022 |
| Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors. J Thorac Dis 11: S71–S80 L Berland, S Heeke, O Humbert, A Macocco, E Long-Mira, S Lassalle S71-S80 CrossRef View in Scopus, 2019 | 5 | 2019 |
| Development of a Stable Peptide–Major Histocompatibility Complex (MHC) via Sortase and Click Chemistry SC Uslu, UJ Lee, S Tavakolpour, O Abousaway, A Nili, L Bass, P Purwar, ... ACS Pharmacology & Translational Science, 2024 | | 2024 |
| Identification of a predictive circulating immunological signature of response to immune checkpoint inhibitors in non-small cell lung cancer W Khatir, O Humbert, J Neels, L Berland, J Benzaquen, FAG Rivera, ... Cancer Research 82 (12_Supplement), 1265-1265, 2022 | | 2022 |
